RIV Capital (TSE:RIV) has released an update.
RIV Capital Inc. and Cansortium Inc. have received approval from the New York Cannabis Control Board for their business combination, with expected closure in Q4 of 2024. This merger aims to create a leading multistate cannabis platform, leveraging RIV’s current momentum from adult-use sales and Cansortium’s medical program expertise to meet the rising demand in New York.
For further insights into TSE:RIV stock, check out TipRanks’ Stock Analysis page.